Literature DB >> 6246261

Specificity of protein synthesis inhibitors in the inhibition of encephalomyocarditis virus replication.

T V Ramabhadran, R E Thach.   

Abstract

Effect of protein synthesis inhibitors on encephalomyocarditis virus production in L-cells was studied. Inhibition of initiation by hypertonicity, harringtonine, or pactamycin decreased viral protein synthesis to a lesser extent than that of host. Virus yield was unaffected or actually enhanced by low concentrations of these inhibitors. On the contrary, the elongation inhibitors cycloheximide, anisomycin, and emetine, shown previously to inhibit viral protein synthesis preferentially, had a greater effect on virus yield than on overall protein synthesis. These results support our earlier proposal that the antiviral activity of cycloheximide derives from its specific effect on the rate of elongation of protein synthesis, and that elongation inhibitors in general may show varying degrees of specific antiviral activity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6246261      PMCID: PMC288699     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  Selective blockage of initiation of host protein synthesis in RNA-virus-infected cells.

Authors:  D L Nuss; H Oppermann; G Koch
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

2.  Inhibition of protein synthesis in intact HeLa cells.

Authors:  J S Tscherne; S Pestka
Journal:  Antimicrob Agents Chemother       Date:  1975-10       Impact factor: 5.191

3.  Harringtonine, an inhibitor of initiation of protein biosynthesis.

Authors:  M T Huang
Journal:  Mol Pharmacol       Date:  1975-09       Impact factor: 4.436

4.  Inhibitors of protein synthesis in eukaryotes: tools in cell research.

Authors:  A P Grollman; M T Huang
Journal:  Fed Proc       Date:  1973-06

5.  Selective and reversible inhibition of initiation of protein synthesis in mammalian cells.

Authors:  J L Saborio; S S Pong; G Koch
Journal:  J Mol Biol       Date:  1974-05-15       Impact factor: 5.469

6.  Model for the regulation of mRNA translation applied to haemoglobin synthesis.

Authors:  H F Lodish
Journal:  Nature       Date:  1974-10-04       Impact factor: 49.962

7.  Control of initiation of protein synthesis in human cells. Evidence for a role of uncharged transfer ribonucleic acid.

Authors:  M H Vaughan; B S Hansen
Journal:  J Biol Chem       Date:  1973-10-25       Impact factor: 5.157

8.  Alpha and beta globin messenger ribonucleic acid. Different amounts and rates of initiation of translation.

Authors:  H F Lodish
Journal:  J Biol Chem       Date:  1971-12-10       Impact factor: 5.157

9.  Differential inhibition of vesicular stomatitis virus polypeptide synthesis by hypertonic initiation block.

Authors:  D L Nuss; G Koch
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

10.  Encephalomyocarditis virus infection of mouse plasmacytoma cells. I. Inhibition of cellular protein synthesis.

Authors:  C Lawrence; R E Thach
Journal:  J Virol       Date:  1974-09       Impact factor: 5.103

View more
  10 in total

1.  Minigenome-based reporter system suitable for high-throughput screening of compounds able to inhibit Ebolavirus replication and/or transcription.

Authors:  Luke D Jasenosky; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Antimicrob Agents Chemother       Date:  2010-04-26       Impact factor: 5.191

2.  Lactimidomycin is a broad-spectrum inhibitor of dengue and other RNA viruses.

Authors:  Margot Carocci; Priscilla L Yang
Journal:  Antiviral Res       Date:  2016-02-10       Impact factor: 5.970

3.  Translational elongation rate changes in encephalomyocarditis virus-infected and interferon-treated cells.

Authors:  T V Ramabhadran; R E Thach
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

4.  Identification of novel antipoxviral agents: mitoxantrone inhibits vaccinia virus replication by blocking virion assembly.

Authors:  Liang Deng; Peihong Dai; Anthony Ciro; Donald F Smee; Hakim Djaballah; Stewart Shuman
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

5.  Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression.

Authors:  Parveen Kaur; Meerra Thiruchelvan; Regina Ching Hua Lee; Huixin Chen; Karen Caiyun Chen; Mah Lee Ng; Justin Jang Hann Chu
Journal:  Antimicrob Agents Chemother       Date:  2012-10-22       Impact factor: 5.191

Review 6.  Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies.

Authors:  Julie Dyall; Robin Gross; Jason Kindrachuk; Reed F Johnson; Gene G Olinger; Lisa E Hensley; Matthew B Frieman; Peter B Jahrling
Journal:  Drugs       Date:  2017-12       Impact factor: 9.546

7.  Antiviral activity of anisomycin against spring viraemia of carp virus in epithelioma papulosum cyprini cells and zebrafish.

Authors:  Yu-Feng Shen; Yang Hu; Bin Zhu; Gao-Xue Wang
Journal:  Virus Res       Date:  2019-05-25       Impact factor: 3.303

8.  A protein interaction map identifies existing drugs targeting SARS-CoV-2.

Authors:  Claudia Cava; Gloria Bertoli; Isabella Castiglioni
Journal:  BMC Pharmacol Toxicol       Date:  2020-09-03       Impact factor: 2.483

9.  Harringtonine Inhibits Zika Virus Infection through Multiple Mechanisms.

Authors:  Zheng-Zong Lai; Yi-Jung Ho; Jeng-Wei Lu
Journal:  Molecules       Date:  2020-09-07       Impact factor: 4.411

Review 10.  Potential Antiviral Action of Alkaloids.

Authors:  Frage L Abookleesh; Bader S Al-Anzi; Aman Ullah
Journal:  Molecules       Date:  2022-01-28       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.